AMA submission to the TGA on codeine and sildenafil scheduling proposal

6 Jul 2018

The AMA supports retaining the existing scheduling for codeine and sildenafil. Considerable analysis and public consultation contributed to the recent codeine up-scheduling decision. The TGA has only recently rejected an application by pharmaceutical companies allow sildenafil to be purchased without a prescription. The AMA is not aware of any new evidence supporting any changes to scheduling for either medicines.